The bearish sentiment is expected to prevail, given the weakness in technical indicators. Below are some short-term trading ideas to consider.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1875 in its research report dated August 01, 2025.
The market may continue to consolidate with a negative bias in the upcoming sessions. Below are some short-term trading ideas to consider.
Stocks to Watch, 25 July: Stocks like Sun Pharma, eClerx Services, Indian Energy Exchange, Anant Raj, REC, Aether Industries, Larsen & Toubro, Torrent Power, Enviro Infra Engineers, GR Infraprojects, and Adani Enterprises will be in focus on July 25.
The market needs to reclaim and sustain above the 20-day EMA to witness a further northward journey in the upcoming sessions. Below are some short-term trading ideas to consider.
Stocks to Watch, 15 July: Stocks like HCL Technologies, Tata Technologies, Rallis India, Power Mech Projects, RailTel Corporation of India, Sun Pharmaceutical Industries, Deepak Fertilisers, and Oberoi Realty will be in focus on July 15.
The market is expected to remain directionless in the upcoming sessions. Below are some short-term trading ideas to consider.
Stocks to watch, 16 June: Gujarat Themis Biosyn, Godrej Properties, Sun Pharmaceutical Industries, Belrise Industries, Syngene International, Natco Pharma, Vedanta, ITC, Eicher Motors, South Indian Bank, NTPC, Nazara Technologies, Scoda Tubes, Shalby, Jubilant Pharmova, Jubilant Foodworks, and Jubilant Ingrevia will be in focus on June 16.
Stocks to watch, 4 June: Stocks like Sun Pharmaceutical Industries, Zydus Lifesciences, Techno Electric & Engineering Company, R Systems International, NMDC, Tata Technologies, Indegene, Aditya Birla Fashion and Retail, Alkem Laboratories, HDFC Bank, Wipro, Servotech Renewable Power Systems, and Scoda Tubes will be in focus on June 4.
Deven Choksey recommended accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1811 in its research report dated May 28, 2025.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2000 in its research report dated May 23, 2025.
Stocks to Watch, 23 May: Stocks like TD Power Systems, MITCON Consultancy & Engineering Services, Trent, Bharat Electronics, Nestle India, IndusInd Bank, Power Mech Projects,Metro Brands, MTAR Technologies, Honasa Consumer, Sun Pharmaceutical Industries, and ITC will be in focus on May 23.
Stocks to Watch, 19 May: Stocks like Zen Technologies, Arvind Fashions, Galaxy Surfactants, KRBL, Kalpataru Projects International, IOL Chemicals, Repco Home Finance, CreditAccess Grameen, Dhampur Sugar Mills, Gujarat Alkalies, Kaynes Technology India, Texmaco Rail & Engineering, Sterlite Technologies, and Dr Reddy's Laboratories will be in focus on May 19.
Stocks to Watch, 07 May: Stocks like eMudhra, KEI Industries, Piramal Enterprises, Aarti Drugs, Aptus Value Housing Finance India, Kansai Nerolac Paints, Shriram Finance, Sun Pharmaceutical Industries, Life Insurance Corporation of India, Prestige Estates Projects, Restaurant Brands Asia, and Gujarat Mineral Development Corporation will be in focus on May 7.
After a consistent five-day rally, the market may consolidate, though the overall trend remains positive. Below are some trading ideas for the near term.
Stocks to Watch, 11 Apr: Stocks like TARC, Bharti Hexacom, Infosys, Aurobindo Pharma, Bharat Heavy Electricals, Bank of India, Tata Steel, Sanofi India, Punjab National Bank, Axiscades Technologies, JSW Energy, Eternal, Federal Bank, Bajaj Healthcare, SRF, Samvardhana Motherson International, IIFL Finance, and Northern Arc Capital will be in focus on April 11.
There is possibility that Nifty can consolidate in between 22,250-22,877 levels in this week. A breach below 22,250 might signal again resumption of down move for possible retest off 21,800 levels, said Ashish Kyal.
Despite likely consolidation in the market, experts advised buying 8 stocks for the next week.
ICICI Securities is bullish on Sun Pharmaceutical Industries recommended buy rating on the stock with a target price of Rs 1895 in its research report dated March 11, 2025.
The index is expected to extend its southward move in the upcoming sessions, given the negative sentiment. Below are some trading ideas for the near term.
KR Choksey recommended Accumulate rating on Sun Pharmaceutical Industries with a target price of Rs 1967 in its research report dated February 04, 2024.
Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 2275 in its research report dated February 01, 2025.